For more than 30 years, CDL has advanced access to cardiac imaging by supporting programs from early adoption through long-term growth, helping reduce barriers to entry while delivering predictable, scalable models. CDL is the #1 provider of custom Cardiac PET and PET/CT suite buildouts in the US, supporting more than 200 Cardiac PET and PET/CT labs nationwide.
Cardiac PET is widely recognized as one of the most accurate noninvasive tests for evaluating coronary artery disease. The American Society of Nuclear Cardiology (ASNC) recommends PET MPI, when available, as a preferred modality for appropriate patients due to its diagnostic accuracy, risk stratification, and quantitative capabilities.*
A Partnership Built for Long-Term Success
CDL Nuclear works alongside your team at every stage of your Cardiac PET program, from early evaluation through implementation and ongoing optimization, providing continued support across planning, staffing, training, and operations. The result is a more aligned, efficient program built to grow and evolve as your needs change.
Rather than only offering a single model, Cardiac PET 360 is CDL Nuclear’s comprehensive, flexible approach, designed to meet practices where they are today and evolve alongside each organization’s clinical, operational, and volume needs.
Through scalable deployment pathways, including On-Demand Mobile Rubidium-82, Flurpiridaz F18 capabilities, Mobile and Fixed Cardiac PET/CT Trailers, and Custom PET/CT Suites, healthcare organizations can provide advanced cardiac imaging on their terms.
Support for Every Stage of Cardiac PET Adoption
By combining infrastructure, clinical expertise, and flexible delivery models, CDL Nuclear helps healthcare providers expand access to advanced cardiac imaging, bringing high-quality cardiac care closer to the patients who need it.
Early-Stage Programs
On-Demand Rubidium-82 and flexible access models support organizations at the beginning of adoption or when managing intermittent volume.
Growing Programs
Mobile Cardiac PET/CT offers immediate access through a fully equipped, staffed solution that integrates with existing workflows.
Established Programs
Custom Cardiac PET/CT suites and fixed mobile solutions support long-term growth with permanent or dedicated infrastructure.
Why CDL Nuclear Technologies
Successful Cardiac PET programs require more than imaging technology. That is why CDL Nuclear provides guidance across program development, implementation, and ongoing needs, helping ensure consistent performance, confident execution, and scalable growth.
With Cardiac PET 360, organizations gain not only access to advanced imaging but also a partner committed to clarity, performance, and long-term success.
Start building your Cardiac PET strategy and connect with the CDL Team today.
* Bateman TM, Al-Mallah MH, Alnabelsi TS, et al. “Clinical indications for positron emission tomography myocardial perfusion imaging and myocardial blood flow quantification: An American Society of Nuclear Cardiology position statement.” Journal of Nuclear Cardiology. March 2026
